Michael Waggoner, DO, has become the first ophthalmologist in the state of Arkansas to implant Johnson and Johnson Vision’s new monofocal intraocular lens (IOL).
Waggoner, with BoozmanHof in Northwest Arkansas, implanted the TECHNIS Eyhance™ lens, which is the newest innovation in Johnson and Johnson’s cataract lens implant line. First released in Europe in 2019, the implant was approved by the U.S. Food and Drug Administration (FDA) on Feb. 1, 2021.
“The design of the Eyhance lens increases the depth of visual focus and improves low-light contrast vision after surgery. For good candidates, this translates into shaper vision in bright and low light settings,” Waggoner said in a statement.
“As monofocal lenses account for 85-90 percent of the lenses we use in cataract surgery, the Eyhance IOL is an exciting addition to the options we have available to achieve the best possible outcomes for our patients.”
After graduating from Rogers High School and the University of Arkansas, Waggoner attended University of North Texas-TCOMand completed an ophthalmology residency at the University of Missouri with a subspecialty fellowship in cataract, LASIK, and corneal disease at the Dean McGee Eye Institute.
Waggoner is the only fellowship-trained LASIK surgeon in Northwest Arkansas.
He is certified by the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, International Society of Refractive Surgery.